Expression of the cardiac ryanodine receptor in the compensated phase of hypertrophy in rat heart

Cardiovascular Research

Volumn 32, Issue 2, 1996, Pages 258-265

  Rannou, Françoise ^a   Dambrin, Grégoire ^a   Marty, Isabelle ^b   Carré, François ^a   Trouvé, Pascal ^a   Lompré, Anne Marie ^c   Charlemagne, Danièle ^a  

^a INSERM   (France)

^b CEA GRENOBLE   (France)

^c CNRS   (France)

Author keywords

Hypertrophy; Rat, ventricle; Ryanodine; SR, calcium release

Indexed keywords

RYANODINE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DISEASE SEVERITY; HEART LEFT VENTRICLE HYPERTROPHY; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RECEPTOR DENSITY; RECEPTOR GENE;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CALCIUM CHANNELS; CALMODULIN-BINDING PROTEINS; CARDIOMEGALY; HEART VENTRICLES; MALE; MUSCLE PROTEINS; RATS; RATS, WISTAR; RNA, MESSENGER; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 0030222271     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00095-8     Document Type: Article

References (37)

1. [1] Imagawa T, Smith S, Coronado R, Campbell KP. Cardiac ryanodine is absent in type I slow skeletal mucle fibers: immunochemical and ryanodine binding studies. J Biol Chem 1987;262:16636-16643.
2. 2+, adenine nucleotide, and calmodulin. J Biol Chem 1987;262:3065-3073.
3. [3] Rardon DP, Cefali DC, Mitchell RD, Seiler SM, Jones LR. High molecular weight proteins purified from cardiac junctional sarcoplasmic reticulum vesicles are ryanodine-sensitive calcium channels. Circ Res 1989;64:779-789.
4. [4] Coronado R, Morrissette J, Sukhareva M, Vaughan DM. Structure and function of ryanodine receptors. Am J Physiol 1994;266:C1485-C1504.
5. 2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J Biol Chem 1990;265:13472-13483.
6. 2+ release channel (ryanodine receptor) skeletal muscle sarcoplasmic reticulum. J Biol Chem 1990;265:2244-2256.
7. [7] Gwathmey JK, Morgan JP. Altered calcium handling in experimental pressure-overload hypertrophy in the ferret. Circ Res 1985;57:836-843.
8. [8] Morgan JP, Erny RE, Allen PD, Grossman W, Gwathmey JK. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 1990;81(suppl III):21-32.
9. [9] Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 1994;74:555-564.
10. [10] Lompré AM, Anger M, Levitsky D. Sarco(endo)plasmic reticulum calcium pumps in the cardiovascular system: function and gene expression. J Mol Cell Cardiol 1994;26:1109-1121.
11. [11] Meyer M, Schillinger W, Pieske B. et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995;92:778-784.
12. [12] Arai M, Alpert NR, MacLennan DH. Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. Circ Res 1993;72:463-469.
13. 2+-ATPase in failing and nonfailing human myocardium. Circ Res 1994;75:434-442.
14. 2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res 1990;66:554-564.
15. 2+ dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum. Regulation of its expression by pressure overload and developmental stage. J Clin Invest 1989;83:1102-1108.
16. 2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ Res 1995;77:759-764.
17. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation 1994;90:653-657.
18. [18] Naudin V. Oliviero P, Rannou F, Sainte Beuve C, Charlemagne D. The density of ryanodine receptors decreases with pressure overload-induced rat cardiac hypertrophy. FEBS Lett 1991;285:135-138.
19. [19] Rannou F, Sainte Beuve C, Oliviero P, Do E, Trouvé P, Charlemagne D. The effects of compensated cardiac hypertrophy on dihydropyridine and ryanodine receptors in rat, ferret, and guinea pig hearts. J Mol Cell Cardiol 1995;27:1225-12234.
20. 2+ channel in SR from dogs with heart failure. Am J Physiol 1993;264:H926-H937.
21. [21] Vatner DE, Sato N, Kiuchi K, Shannon RP, Vatner SR. Decrease in myocardial ryanodine receptors and altered excitation-contraction coupling early in the development of heart failure. Circulation 1994;90:1423-1430.
22. [22] Sapp JL, Howlett SE. Density of ryanodine receptors is increased in sarcoplasmic reticulum from prehypertrophic cardiomyopathic hamster heart. J Mol Cell Cardiol 1992;26:325-334.
23. [23] Finkel MS, Shen L. Romeo RC, Oddis CV, Salama G. Radioligand binding and effects of ryanodine in the cardiomyopathic Syrian Hamster. J Cardiovasc Pharmacol 1990:19:610-617.
24. [24] Lachnit WG, Phillips M, Gayman KJ, Pessah IN. Ryanodine and dihydropyridine binding patterns and ryanodine receptor mRNA levels in myopathic hamster heart. Am J Physiol 1994;267:H1205-H1213.
25. [25] Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 1995;95:888-894.
26. [26] Brillantes AM, Allen P, Takahashi T. Izumo S, Marks R. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure due to ischemic versus dilated cardiomyopathy. Circ Res 1992;78:18-26.
27. 2+ accumulation in nonfailing and failing human myocardium. Circulation 1995;92:2504-2510.
28. [28] Chirgwin JJ, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 1979;18:5294-5299.
29. [29] Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4354.
30. [30] Marty I, Robert M, Villaz M, De Jongh KS, Lai Y, Catterall WA, Ronjat M. Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of skeletal muscle. Proc Natl Acad Sci USA 1994;91:2270-227.
31. [31] Timerman PA, Ogunbumni E, Freund E, Wiederrecht G, Marks RA, Fleischer S. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. J Biol Chem 1993;268:22992-22999.
32. [32] Mack MM. Molinski TF. Buck ED, Pessah IN. Novel modulators of skeletal muscle FKBP12/calcium channel complex from lanthella bastci. J Biol Chem 1994;269:23236-23249.
33. [33] Schwartz K, Mercadier JJ, Swynghedauw B, Lompré AM. Modifications of gene expression in cardiac hypertrophy. Heart Failure 1988;4:154-163.
34. [34] Magid NR, Borer JS, Young MS, Wallerson DC, DeMonteiro C. Suppression of protein degradation in progressive cardiac hypertrophy of chronic aortic regurgitation. Circulation 1993;87:1249-1257.
35. [35] Siri FM, Krueger J, Nordin C, Ming Z, Aronson RS. Depressed intracellular calcium transients and contraction in myocytes from hypertrophied and failing guinea pig hearts. Am J Physiol 1991;261:H514-H530.
36. 2+ cycle in congestive heart failure produced in dogs by idiopathic dilated cardiomyopathy and rapid ventricular pacing. J Mol Cell Cardiol 1994:26:173-184.
37. [37] Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 1993. 73:184-192.